[Prospective study of the immunomodulator properties of i.m. administered "ALVA" extract in patients with solid tumors under a course of chemical immunosuppressive therapy].
Michel
P
P
Institut Pasteur Antannerivo.
Pignon
T
T
Ralamboranto
L
L
Randrianandraina
S
S
Ratovonarivo
A
A
Coulanges
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000504:Aloe; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D009369:Neoplasms / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D010946:Plants, Medicinal; D011446:Prospective Studies
D000276:Adjuvants, Immunologic; D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts
Etude prospective des propriétés immunomodulatrices de l'extrait "ALVA" utilisé en "I.M." chez des patients atteints de tumeurs solides et en cours de thérapie immunosuppressive chimique.